Women's testosterone supplements

Information from the Nurses' Health Study indicated that the combination of estrogen and androgen used to treat hypoandrogenism could increase breast cancer risk. However, other studies indicated androgens may decrease breast cancer risk. Follow-up studies on the Women's Health Initiative found women who received estrogen and no progestogen showed a significant decrease in cardiovascular disease (CVD) and breast cancer. This has caused a reconsideration of androgens added to estrogens. Still, the FDA requires demonstration of CVD and breast cancer safety for any product containing androgens or estrogen plus an androgen; that has not been done.

It is suggested that bioavailable testosterone represents the fraction of circulating testosterone that readily enters cells and better reflects the bioactivity of testosterone than does the simple measurement of serum total testosterone. Also, varying levels of SHBG can result in inaccurate measurements of bioavailable testosterone. Decreased SHBG levels can be seen in obesity, hypothyroidism , androgen use, and nephritic syndrome (a form of kidney disease ). Increased levels are seen in cirrhosis , hyperthyroidism , and estrogen use. In these situations, measurement of free testosterone may be more useful.

Kraft, S. (.). Signs of high testosterone in women. Retrieved from  http:///content/article/signs-high-testosterone-women

Low testosterone. (2012, March). Retrieved from  http:///diseases-and-conditions/mens-health/low-testosterone

Nigro, N. & Christ-Cain, M. (2012). Testosterone treatment in the aging male: Myth or reality? Swiss Medicine Weekly, 2012(142), w13539. Retrieved from  http:///content/smw-2012-13539/

NIH-supported trials of testosterone therapy in older men report mixed results. (2017, February 21). Retrieved from  https:///news-events/news-releases/nih-supported-trials-testosterone-therapy-older-men-report-mixed-results

Sharma, R., Oni, O. A., Gupta, K., Chen, G., Sharma, M., Dawn, B., … & Barua, R. S. (2015, August 6). Normalization of testosterone level is associated with reduced incidence of myocardial infarction. European Heart Journal, 36(40), 2706-2715. Retrieved from  https:///eurheartj/article/36/40/2706/2293361/Normalization-of-testosterone-level-is-associated

Sinicki, A. (.). What are prohormones? Are they safe? Retrieved from http:///entry/17328/1/What-Are-Prohormones-And-Are-They-

Testosterone and androgens. (2014, January). Retrieved from  http:///hormones-and-health/hormones/testosterone

Tsujimura, A. (2013, August 31). The relationship between testosterone deficiency and men's health.  The World Journal of Men's Health, 31 (2), 126-135. Retrieved from  http:///pmc/articles/PMC3770847/

Walker, W. H. (2010, May 27). Non-classical actions of testosterone and spermatogenesis.  Philosophical Transactions of the Royal Society of London Series B, 365 (1546). Retrieved from  http:///pmc/articles/PMC2871922/

Wein, H. (2013, September 23). Understanding how testosterone affects men. Retrieved from  https:///news-events/nih-research-matters/understanding-how-testosterone-affects-men

What is low testosterone (hypogonadism)? (.). Retrieved from  https:///urologic-conditions/low-testosterone-(hypogonadism)

Wong, J. Y. Y., Gold, E. B., Johnson, W. O., & Lee, J. S. (2015, October 2015). Circulating sex hormones and risk of uterine fibroids: Study of women's health across the nation (SWAN).  The Journal of Clinical Endocrinology & Metabolism, 101 (1), 123-130. Retrieved from  http:///doi//-2935

Ziegenfuss, T. N., Berardi, J. M., & Lowery, L. M. (2002, December). Effects of prohormone supplementation in humans: A review [Abstract]. Canadian Journal of Applied Physiology, 27 (6), 628-646. Retrieved from https:///pubmed/12501001

Women's testosterone supplements

women's testosterone supplements


women's testosterone supplementswomen's testosterone supplementswomen's testosterone supplementswomen's testosterone supplementswomen's testosterone supplements